Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke.

Hawkins KE, DeMars KM, Singh J, Yang C, Cho HS, Frankowski JC, Doré S, Candelario-Jalil E.

J Neurochem. 2014 Apr;129(1):130-42. doi: 10.1111/jnc.12607. Epub 2013 Dec 1.

2.

Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery.

Hawkins KE, DeMars KM, Alexander JC, de Leon LG, Pacheco SC, Graves C, Yang C, McCrea AO, Frankowski JC, Garrett TJ, Febo M, Candelario-Jalil E.

Brain Behav. 2017 Apr 12;7(5):e00688. doi: 10.1002/brb3.688. eCollection 2017 May.

3.

BML-111 attenuates hemorrhagic shock-induced acute lung injury through inhibiting activation of mitogen-activated protein kinase pathway in rats.

Li HB, Wang GZ, Gong J, Wu ZY, Guo S, Li B, Liu M, Ji YD, Tang M, Yuan SY, Shang Y, Yao SL.

J Surg Res. 2013 Aug;183(2):710-9. doi: 10.1016/j.jss.2013.03.007. Epub 2013 Mar 26.

PMID:
23558258
4.

BML-111, a lipoxin receptor agonist, attenuates ventilator-induced lung injury in rats.

Li H, Wu Z, Feng D, Gong J, Yao C, Wang Y, Yuan S, Yao S, Shang Y.

Shock. 2014 Apr;41(4):311-6. doi: 10.1097/SHK.0000000000000104.

PMID:
24365886
5.

Dual role of lipoxin A4 in pneumosepsis pathogenesis.

Sordi R, Menezes-de-Lima O Jr, Horewicz V, Scheschowitsch K, Santos LF, Assreuy J.

Int Immunopharmacol. 2013 Oct;17(2):283-92. doi: 10.1016/j.intimp.2013.06.010. Epub 2013 Jun 28.

6.

Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.

Wang Y, Jia J, Ao G, Hu L, Liu H, Xiao Y, Du H, Alkayed NJ, Liu CF, Cheng J.

J Neurochem. 2014 Jun;129(5):827-38. doi: 10.1111/jnc.12695. Epub 2014 Mar 27.

7.

Continuous oral administration of atorvastatin ameliorates brain damage after transient focal ischemia in rats.

Saito T, Nito C, Ueda M, Inaba T, Kamiya F, Muraga K, Katsura K, Katayama Y.

Life Sci. 2014 Jan 17;94(2):106-14. doi: 10.1016/j.lfs.2013.11.018. Epub 2013 Dec 9.

PMID:
24333133
9.

Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke.

DeMars KM, McCrea AO, Siwarski DM, Sanz BD, Yang C, Candelario-Jalil E.

Front Neurosci. 2018 Feb 20;12:89. doi: 10.3389/fnins.2018.00089. eCollection 2018.

10.

Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.

Cui L, Zhang X, Yang R, Wang L, Liu L, Li M, Du W.

Brain Res. 2010 Apr 14;1325:164-73. doi: 10.1016/j.brainres.2010.02.036. Epub 2010 Feb 16.

PMID:
20167207
11.

Lipoxin A4 Reduces Inflammation Through Formyl Peptide Receptor 2/p38 MAPK Signaling Pathway in Subarachnoid Hemorrhage Rats.

Guo Z, Hu Q, Xu L, Guo ZN, Ou Y, He Y, Yin C, Sun X, Tang J, Zhang JH.

Stroke. 2016 Feb;47(2):490-7. doi: 10.1161/STROKEAHA.115.011223. Epub 2016 Jan 5.

12.

Calycosin-7-O-β-D-glucoside regulates nitric oxide /caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury.

Fu S, Gu Y, Jiang JQ, Chen X, Xu M, Chen X, Shen J.

J Ethnopharmacol. 2014 Aug 8;155(1):692-701. doi: 10.1016/j.jep.2014.06.015. Epub 2014 Jun 12.

PMID:
24930357
13.

Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection.

Martini AC, Berta T, Forner S, Chen G, Bento AF, Ji RR, Rae GA.

J Neuroinflammation. 2016 Apr 8;13(1):75. doi: 10.1186/s12974-016-0540-8.

14.

In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.

Petty MA, Neumann-Haefelin C, Kalisch J, Sarhan S, Wettstein JG, Juretschke HP.

Eur J Pharmacol. 2003 Aug 1;474(1):53-62.

PMID:
12909195
15.

Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia.

Bhattacharya P, Pandey AK, Paul S, Patnaik R.

Life Sci. 2014 Apr 1;100(2):97-109. doi: 10.1016/j.lfs.2014.01.085. Epub 2014 Feb 14.

PMID:
24530291
16.

Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes.

Kong X, Wu SH, Zhang L, Chen XQ.

Exp Ther Med. 2017 Sep;14(3):2284-2290. doi: 10.3892/etm.2017.4787. Epub 2017 Jul 12.

17.

Acute hyperglycemia worsens ischemic stroke-induced brain damage via high mobility group box-1 in rats.

Huang J, Liu B, Yang C, Chen H, Eunice D, Yuan Z.

Brain Res. 2013 Oct 16;1535:148-55. doi: 10.1016/j.brainres.2013.08.057. Epub 2013 Sep 5.

PMID:
24012767
18.

Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.

Culman J, Nguyen-Ngoc M, Glatz T, Gohlke P, Herdegen T, Zhao Y.

Exp Neurol. 2012 Dec;238(2):243-53. doi: 10.1016/j.expneurol.2012.09.003. Epub 2012 Sep 17.

PMID:
22995601
19.

Propofol protects against focal cerebral ischemia via inhibition of microglia-mediated proinflammatory cytokines in a rat model of experimental stroke.

Zhou R, Yang Z, Tang X, Tan Y, Wu X, Liu F.

PLoS One. 2013 Dec 9;8(12):e82729. doi: 10.1371/journal.pone.0082729. eCollection 2013.

20.

Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions.

Fukuta T, Ishii T, Asai T, Sato A, Kikuchi T, Shimizu K, Minamino T, Oku N.

Eur J Pharm Biopharm. 2015 Nov;97(Pt A):1-7. doi: 10.1016/j.ejpb.2015.09.020. Epub 2015 Oct 9.

PMID:
26455340

Supplemental Content

Support Center